Distributed to the Medical/Healthcare sector by In Vitro Technologies.
Coronavirus Panel
About Us
In Vitro Technologies’ Diagnostics Division represents leading global companies in both Clinical and Veterinary Pathology, to deliver customised solutions for all areas of pathology.
Each Diagnostics team member have extensive laboratory and commercial experience and, along with technical support and customer care professionals, are committed to providing quality and responsive after-sales service and support.
Learn more about our customised solutions
All news
Latest News & Events
Dec 3, 2016
Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
Avivi I, Cohen YC, Joffe E, Benyamini N, Held-Kuznetsov V, Trestman S, et al. Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome. Hematol Oncol 2016.
Dec 3, 2016
Evaluation of the Impact of Renal Failure on Correlation and Concordance between 2 Free Light Chain Assays
Moreau C, Autier B, Cavey T, Rouger E, Norwood J, Bendavid C, et al. Evaluation of the Impact of Renal Failure on Correlation and Concordance between 2 Free Light Chain Assays. Clin Lymphoma Myeloma Leuk 2016.
Nov 16, 2016
AIMS & AACB Christmas Quiz
All we want for Christmas is for you to join us for Trivia! The Queensland Branch of AIMS and AACB would like to invite you to this year’s joint Christmas Quiz and Function.
